RU93058325A - APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS - Google Patents
APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITISInfo
- Publication number
- RU93058325A RU93058325A RU93058325/14A RU93058325A RU93058325A RU 93058325 A RU93058325 A RU 93058325A RU 93058325/14 A RU93058325/14 A RU 93058325/14A RU 93058325 A RU93058325 A RU 93058325A RU 93058325 A RU93058325 A RU 93058325A
- Authority
- RU
- Russia
- Prior art keywords
- hepatitis
- treatment
- application
- derivatives
- oxathyolane
- Prior art date
Links
- WJJSZTJGFCFNKI-UHFFFAOYSA-N 1,3-oxathiolane Chemical class C1CSCO1 WJJSZTJGFCFNKI-UHFFFAOYSA-N 0.000 title claims 2
- 208000006454 Hepatitis Diseases 0.000 title 2
- 231100000283 hepatitis Toxicity 0.000 title 2
- 206010047461 Viral infection Diseases 0.000 title 1
- 208000001756 Virus Disease Diseases 0.000 title 1
- 239000003814 drug Substances 0.000 title 1
- 238000004519 manufacturing process Methods 0.000 title 1
- 230000002265 prevention Effects 0.000 title 1
- 230000017613 viral reproduction Effects 0.000 title 1
- 208000002672 Hepatitis B Diseases 0.000 claims 1
- 239000002777 nucleoside Substances 0.000 claims 1
- 150000003833 nucleoside derivatives Chemical class 0.000 claims 1
- 239000000825 pharmaceutical preparation Substances 0.000 claims 1
Claims (1)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
GB919109506A GB9109506D0 (en) | 1991-05-02 | 1991-05-02 | Therapeutic nucleosides |
GB9109506.7 | 1991-05-02 | ||
PCT/GB1992/000803 WO1992019246A1 (en) | 1991-05-02 | 1992-05-01 | Use of a 1,3-oxathiolan derivative for the treatment of hepatitis b infection |
Publications (2)
Publication Number | Publication Date |
---|---|
RU93058325A true RU93058325A (en) | 1997-01-27 |
RU2104700C1 RU2104700C1 (en) | 1998-02-20 |
Family
ID=10694346
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU93058325A RU2104700C1 (en) | 1991-05-02 | 1992-05-01 | Method of hepatitis b treatment |
Country Status (14)
Country | Link |
---|---|
EP (1) | EP0583274A1 (en) |
JP (1) | JPH06506929A (en) |
AU (1) | AU1662092A (en) |
CA (1) | CA2102120A1 (en) |
GB (1) | GB9109506D0 (en) |
IE (1) | IE921363A1 (en) |
IL (1) | IL101757A0 (en) |
MX (1) | MX9203214A (en) |
MY (1) | MY137298A (en) |
PT (1) | PT100435B (en) |
RU (1) | RU2104700C1 (en) |
UA (1) | UA37251C2 (en) |
WO (1) | WO1992019246A1 (en) |
ZA (1) | ZA923185B (en) |
Families Citing this family (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5684164A (en) | 1988-04-11 | 1997-11-04 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
US5466806A (en) * | 1989-02-08 | 1995-11-14 | Biochem Pharma Inc. | Processes for preparing substituted 1,3-oxathiolanes with antiviral properties |
IL100502A (en) * | 1991-01-03 | 1995-12-08 | Iaf Biochem Int | Pharmaceutical compositions containing cis-4-amino-1(hydroxymethyl-1,3-oxathiolan-5-yl)-1H-pyrimid-2-one nucleoside or its derivatives |
GB9110874D0 (en) * | 1991-05-20 | 1991-07-10 | Iaf Biochem Int | Medicaments |
ZA923640B (en) * | 1991-05-21 | 1993-02-24 | Iaf Biochem Int | Processes for the diastereoselective synthesis of nucleosides |
NZ513094A (en) | 1998-12-23 | 2004-05-28 | Shire Biochem Inc | Antiviral nucleoside analogues |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5159067A (en) * | 1987-01-28 | 1992-10-27 | University Of Georgia Research Foundation Inc. | 5'-Diphosphohexose nucleoside pharmaceutical compositions |
US5047407A (en) * | 1989-02-08 | 1991-09-10 | Iaf Biochem International, Inc. | 2-substituted-5-substituted-1,3-oxathiolanes with antiviral properties |
JPH04501854A (en) * | 1989-05-15 | 1992-04-02 | アメリカ合衆国 | How to treat hepatitis |
US5204466A (en) * | 1990-02-01 | 1993-04-20 | Emory University | Method and compositions for the synthesis of bch-189 and related compounds |
-
1991
- 1991-05-02 GB GB919109506A patent/GB9109506D0/en active Pending
-
1992
- 1992-04-30 MY MYPI92000749A patent/MY137298A/en unknown
- 1992-04-30 ZA ZA923185A patent/ZA923185B/en unknown
- 1992-04-30 PT PT100435A patent/PT100435B/en not_active IP Right Cessation
- 1992-05-01 UA UA93004171A patent/UA37251C2/en unknown
- 1992-05-01 JP JP4508657A patent/JPH06506929A/en active Pending
- 1992-05-01 RU RU93058325A patent/RU2104700C1/en active
- 1992-05-01 WO PCT/GB1992/000803 patent/WO1992019246A1/en not_active Application Discontinuation
- 1992-05-01 AU AU16620/92A patent/AU1662092A/en not_active Abandoned
- 1992-05-01 IL IL101757A patent/IL101757A0/en unknown
- 1992-05-01 EP EP92908933A patent/EP0583274A1/en not_active Withdrawn
- 1992-05-01 CA CA002102120A patent/CA2102120A1/en not_active Abandoned
- 1992-06-24 MX MX9203214A patent/MX9203214A/en unknown
- 1992-07-01 IE IE136392A patent/IE921363A1/en not_active Application Discontinuation
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CA2105486A1 (en) | Therapeutic nucleosides | |
MD1224B2 (en) | Application of nucleoside analogues with 1,3-oxathiolan for treatment of hepatitis B | |
RU94013464A (en) | NUCLEOSIDE ANALOGUES 1,3-OXATIOLANE, METHOD OF OBTAINING, PHARMACEUTICAL COMPOSITION, METHOD OF TREATING VIRAL INFECTION | |
WO2003051306A3 (en) | N4-acylcytosine-1,3-dioxolane nucleosides for treatment of viral infections | |
RU93043875A (en) | 1- (2-HYDROXYMETHYL) -1,3-OXATIOLAN-5-IL) -5-fluorocytosine AND METHOD OF TREATMENT | |
MY107843A (en) | Anti-viral compounds. | |
DK602988A (en) | NUCLEOSIDE DERIVATIVES WITH ANTIVIRAL EFFECT AND PHARMACEUTICAL PREPARATIONS CONTAINING SUCH COMPOUNDS | |
CA2271622A1 (en) | Antiviral agents from plant extracts and use for treatment of viral infections | |
ITMI931522A0 (en) | PHARMACEUTICAL COMPOSITION FOR THE TREATMENT OF HEPATITIS B VIRUS INFECTION (HBV) | |
CA2072573A1 (en) | Treatment of human retroviral infections with 2',3'-dideoxyinosine | |
NO875209D0 (en) | PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5-SUBSTITUTED PYRIMIDINE NUCLEOSIDES. | |
DK92788A (en) | USE OF 3'-DEOXY-3'-FLUORUANOSIDES FOR THE PREPARATION OF MEDICINAL PRODUCTS AGAINST RETROVIRA | |
DE3679353D1 (en) | ANTIVIRAL CONNECTIONS. | |
RU93058325A (en) | APPLICATION OF 1,3-OXATHIOLANE DERIVATIVES FOR PRODUCTION OF MEDICINES FOR THE TREATMENT OR PREVENTION OF HEPATITIS B VIRAL INFECTION, APPLICATION OF 1,3 - OXATHYOLANE DERIVATIVES FOR THE TREATMENT OF HEPATITIS | |
LV10191A (en) | Pharmaceuticals for the treatment of infections and diseases caused by hepatitis B virus | |
DE69019404D1 (en) | Penciclovir derivatives used to treat hepatitis B infections. | |
DE69004451D1 (en) | Prophylaxis and treatment of herpes virus infections. | |
MY137298A (en) | Therapeutic nucleosides | |
IL102815A (en) | Pharmaceutical compositions for the treatment of infection caused by the human immunodeficiency virus | |
MY113560A (en) | Use of 5-fluoro-2'-deoxy-3'-thiacytidine for the treatment of hepatitis b | |
TH13799EX (en) | Anti-HBV Pyrimidine Nucleoside | |
TH13799A (en) | Anti-HBV Pyrimidine Nucleoside | |
RU93046287A (en) | AMINODIOL PROTESIS INHIBITORS | |
WO1988008707A3 (en) | Rubradirin derivatives for treatment of hiv infection | |
AU2880495A (en) | Use of pharmaceutical agents for alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses |